Core Scientific (CORZ) Gets 7.3% Boost from ‘Buy’ Reco

Core Scientific Inc. Overview - Core Scientific Inc. (NASDAQ:CORZ) experienced a significant stock performance improvement, rising 7.30% to close at $14.56, following a "buy" recommendation from an investment firm [1][3] - Citizens investment firm set a price target of $30 for Core Scientific, indicating a 106% upside potential from its latest closing price, and upgraded its rating to "outperform" from "market perform" [2][3] Financial Performance - In Q3, Core Scientific reduced its net loss by 68% to $146.66 million, down from $455 million in the same period last year [4] - The company's revenues declined by 15% to $81.1 million, compared to $95.4 million year-on-year [4] Strategic Insights - The upgrade from Citizens reflects confidence in Core Scientific's growth prospects, particularly in securing high-performance computing (HPC) leasing agreements beyond its existing customer, CoreWeave [3]